Efferon mówi „cześć” Polsce!

We are proud to announce that Efferon has received official authorization in Poland, making it the 42nd country worldwide and the 16th in the EU where our devices are available!

We are delighted to work with our partner West Medical. Their deep knowledge of the Polish healthcare system and long-standing experience in medical distribution will help bring Efferon directly to the clinicians and patients who need it most.

EfferonLPS is a next-generation hemoadsorption device that targets both endotoxins and cytokines, helping to control the systemic inflammatory response in sepsis. With EU approval under the MDR, it offers clinicians a reliable tool to support critical patients when every hour counts.

We can’t wait to hear about the first clinical cases in Poland and see how Efferon makes a difference for patients. Let’s keep moving forward!